(VIANEWS) –

NASDAQ Composite ended the session with Pacific Biosciences of California rising 5% to $31.51 on Thursday, following the last session’s upward trend. NASDAQ Composite jumped 0.11% to $14,778.26, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Pacific Biosciences of California is 1495580, 39.77% below its average volume of 2483000.

Pacific Biosciences of California’s last close was $31.51, 41.31% below its 52-week high of $53.69.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 75% for the current quarter and 68.3% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 33.3% and a negative 50%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 85.9%, now sitting on 92.29M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pacific Biosciences of California’s stock is considered to be overbought (>=80).

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $31.51 at 18:18 EST, way under its 52-week high of $53.69 and way higher than its 52-week low of $3.66.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s value is higher than its 50-day moving average of $30.62 and below its 200-day moving average of $31.90.

More news about Pacific Biosciences of California (PACB).

LEAVE A REPLY

Please enter your comment!
Please enter your name here